Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program.
Galluppi GR, Ahamadi M, Bhattacharya S, Budha N, Gheyas F, Li CC, Chen Y, Dosne AG, Kristensen NR, Magee M, Samtani MN, Sinha V, Taskar K, Upreti VV, Yang J, Cook J.
Galluppi GR, et al. Among authors: magee m.
Clin Pharmacol Ther. 2024 Mar 22. doi: 10.1002/cpt.3245. Online ahead of print.
Clin Pharmacol Ther. 2024.
PMID: 38519861
Review.